Ultra Sakti is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1977. Ultra Sakti, a prominent player in the Indonesian pharmaceutical industry, was founded by the visionary entrepreneur, Mr. Handojo Santosa. The company has established itself as a leader in the production and distribution of over-the-counter (OTC) medications and herbal supplements. Its primary business line focuses on the manufacturing of medicinals and botanicals, while it also engages in secondary activities related to health and wellness products. Ultra Sakti operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products nationwide. The company is renowned for its flagship product, "Bodrex," a popular pain relief medication, and "Komix," a well-known cough syrup brand. These products have become household names in Indonesia, reflecting the company's commitment to quality and consumer trust. In addition to its domestic operations, Ultra Sakti has expanded its footprint to several Southeast Asian countries, enhancing its regional influence. The company collaborates with various international partners to innovate and improve its product offerings, ensuring they meet global standards. Ultra Sakti is a member of several pharmaceutical and health associations, which helps it stay abreast of industry trends and regulatory changes. The company is dedicated to sustainable practices and aims to contribute positively to community health and well-being. With a vision to be a leading provider of health solutions in Asia, Ultra Sakti continues to invest in research and development, focusing on creating effective and affordable healthcare products for its consumers.
Headquarters
Kompleks Gading Bukit Indah Blok R-A No. 03-05
North Jakarta; Jakarta;
Postal Code: 14240
Contact Details: Purchase the PT Ultra Sakti report to view the information.
Website: http://www.ultrasakti.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service